Cardlytics, Inc. (CDLX)

On our desk, the CDLX thesis hinges on whether the post-strategic-reset margin improvements can offset the severe top-line damage from that major financial-institution partner exit. Management is touting Q2 2026 revenue of $36.9 million and positive Adjusted EBITDA of $1.7 million as proof of an operational turnaround, but looking at the 10-Q filing, revenue dropped substantially compared to $58.0 million a year ago. While the Bridg divestiture and PAR share liquidation brought in cash, the balance sheet still carries $172.5 million in convertible notes and a $15 million revolver draw. The market is pricing this like a distressed asset with a $25 million market cap for a reason.

From a quantitative risk perspective, alternative data providers like AltIndex are flashing major red flags with a 29/100 AI score, categorizing CDLX as a 'Sell'. Web traffic trends and fundamental metrics are completely disconnected from the upbeat management tone on the earnings call. Even though billings reached $65.5 million and adjusted contribution hit $21.3 million in Q2, the underlying drop in Monthly Qualified Users and the loss of a key partner create massive execution risk. Until top-line revenue stabilization is definitively proven across multiple quarters rather than just margin cost-cutting, holding a position here requires extreme caution regarding liquidity and debt overhang.

When evaluating CDLX for a fundamental modeling test, you have to separate continuing operations from the noise of the Bridg sale and investment losses. They recorded a $13.9 million gain from the Bridg business sale, but then incurred a $2.4 million loss on PAR share investments, bringing total net loss for Q2 to $(14.9) million. Analysts should focus closely on the operational execution metrics highlighted by CEO Amit Gupta—specifically that margins improved every single month of the quarter and advertiser churn has materially improved. However, factor in the negative ROE of -396.5% and the TTM EPS of -$1.95 when building your long-term discounted cash flow models.